• RG108 Pharmacokinetics and In Vivo DNMT Inhibition

  2026-08-18

  The reference study establishes an in vivo pharmacokinetic profile for RG108, a non-nucleosidic DNA methyltransferase inhibitor designed to avoid DNA incorporation and the cytotoxic liabilities of nucleoside analogues. In rats, subcutaneous dosing produced measurable plasma and tissue exposure within the reported inhibitory range, supporting RG108 as a tool for studying DNA methylation in models where cell division is limited.

• Diuron-Induced Acute Renal Injury: Mechanistic Insights

  2026-08-18

  A 2025 study integrates network toxicology, transcriptomic validation, molecular docking, and HK-2 cell experiments to investigate how Diuron may cause acute kidney injury. Its central finding is that JAK2/STAT1 pathway activation accompanies Diuron-associated renal cell injury, providing a mechanistic framework for environmental toxicology and future risk assessment.

• Self-Adaptive Nanocarriers for Pancreatic Cancer

  2026-08-17

  The ACS Nano study developed a pH/reactive oxygen species dual-sensitive nanocarrier, DATCPT, to coordinate tumor targeting, extracellular matrix remodeling, deep penetration, and camptothecin delivery in orthotopic pancreatic cancer. Its importance lies in treating delivery barriers as a linked physiological sequence rather than as isolated problems, while its redox mechanism also highlights the need for carefully controlled intracellular ROS measurement.

• GDC-0941: Practical PI3K Inhibitor Assays

  2026-08-17

  GDC-0941 supports a practical bridge from rapid PI3K/Akt pathway inhibition assays to therapy-resistance and cancer stem cell studies. This workflow-focused guide covers compound handling, pAKT and apoptosis readouts, HER2-resistant models, HCC-focused assay design, and troubleshooting for reproducible results.

• GDC-0994: ERK1/2 Inhibitor Workflow Guide

  2026-08-16

  GDC-0994 is a potent, selective ERK1/2 inhibitor for connecting pathway-level target engagement with measurable changes in cancer-cell behavior and cholestatic injury models. This workflow guide covers dosing logic, phospho-ERK assay design, zebrafish rescue experiments, and practical troubleshooting for reproducible ERK pathway research.

• Sulfo-NHS-Biotin for Surface-to-Secretome Assays

  2026-08-15

  Sulfo-NHS-Biotin provides a water-compatible route to covalently tag accessible primary amines on proteins and intact cell surfaces. This article explains how to use that surface-defined signal as an orthogonal layer alongside SEC-seq, while avoiding the common mistake of treating surface labeling as a direct readout of secretion.

• X-Gal Workflows for Cloning and Reporter Validation

  2026-08-14

  Turn lacZα-based clone selection into a faster, more interpretable molecular cloning workflow with practical X-Gal setup, controls, and troubleshooting. The same strategy can support construct-quality checks for olfactory receptor studies, while clearly separating cloning readouts from biological activity measurements.

• Halazone Workflows for Water and Nerve Research

  2026-08-14

  Halazone combines rapid oxidative water disinfection with a distinctive neurophysiology use-case: perturbing sodium-current inactivation in myelinated nerve fibers. This guide converts those findings into practical preparation, assay, controls, and troubleshooting workflows for microbiology and electrophysiology laboratories.

• EdU Imaging Kits (Cy3) for S-Phase Assays

  2026-08-13

  EdU Imaging Kits (Cy3) deliver denaturation-free visualization of DNA replication for microscopy and flow cytometry. This practical guide connects assay design with glioblastoma perturbation studies, quantitative analysis, and troubleshooting.

• Taltirelin acetate Workflows for Neuroscience

  2026-08-13

  Taltirelin acetate combines long-acting TRH-receptor signaling with practical utility across sleep, neurodegeneration, itch, and formulation studies. This guide translates the strongest in vivo evidence into executable workflows, assay choices, and troubleshooting strategies.

• Saquinavir: A Membrane-Aware Assay Strategy

  2026-08-12

  Saquinavir is a clinically important HIV protease inhibitor whose assay interpretation benefits from membrane-aware experimental design. This guide connects HIV protease enzymatic pathway studies with IAM LC and LEKC permeability models while clarifying what each method can—and cannot—prove.

• GDC-0941: A Mechanism-First Assay Guide

  2026-08-12

  GDC-0941 is a selective PI3K inhibitor for dissecting PI3K/Akt signaling beyond simple viability measurements. This guide connects pathway pharmacology with assay design, EMT interpretation, and the latest evidence on CDK4/6–BET crosstalk in pancreatic cancer.

• Anisomycin Workflows for JNK Apoptosis Research

  2026-08-11

  Use Anisomycin as a time-resolved JNK agonist for dissecting stress signaling, apoptosis, and pathway-dependent cell vulnerability. This workflow also shows how to use it carefully as a hypothesis-testing perturbation alongside the neuroligin 1 mechanisms that sustain social memory.

• Tobramycin Workflows for Gram-Negative Research

  2026-08-11

  Build reproducible Tobramycin susceptibility, comparator, and resistance experiments with water-based preparation and reference-aligned microdilution parameters. This practical guide connects mechanism, assay design, troubleshooting, and comparative interpretation without turning in-vitro findings into clinical claims.

• Ceftolozane/Tazobactam: Evidence and Research Design

  2026-08-10

  The reference review explains why ceftolozane/tazobactam was developed as an antipseudomonal cephalosporin and β-lactamase inhibitor combination, emphasizing PBP targeting, activity against resistant Gram-negative pathogens, and pharmacokinetic/pharmacodynamic exposure targets. Its practical value lies in connecting microbiology, resistance mechanisms, dosing, renal elimination, clinical-trial evidence, and safety into a framework for interpreting new antibacterial therapies.

16159 records 1/1078 page Next 12345 下5页 Last page